Head-to-head trial result SURMOUNT-5 found tirzepatide produced about 20% average body weight loss versus roughly 14% for semaglutide over 72 weeks in adults with obesity
Related Stories Modest Results in People With Diabetes In April, Lilly shared topline data showing that people with diabetes lost an average of 8% of their body weight after 40 weeks on the highest dose of orforglipron
How much weight can I expect to lose on semaglutide or other weight loss medication
DTC platforms that cut out PBMs become de facto cash-only pharmacies that cannot accept insurance plans, limiting who can benefit from the savings
At TrimRx, we offer quick-access supplements designed to complement your efforts
Key Differences Celtuide A GLP-1 receptor agonist injection containing semaglutide Administered once weekly Helps regulate blood sugar by improving insulin secretion, reducing glucagon release, and slowing digestion Lantus A long-acting insulin (insulin glargine) Administered once daily by injection Provides a steady level of insulin to help control blood glucose levels throughout the day CELTUIDE HELPS CONTROL BLOOD SUGAR AND WEIGHT CELTUIDE is a prescription medicine used to help adults with type 2 diabetes improve blood sugar control when used along with a balanced diet and regular physical activity
